MetaTOC stay on top of your field, easily

The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries – For Whom, by Whom and Where?

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Clinical and Applied Thrombosis/Hemostasis

Published online on

Abstract

Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
Hemophilia, a congenital deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B), leads to recurrent bleeding episodes that may cause progressive joint damage and long-term disability. Traditional management relies on intravenous factor ...